Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular …

A Payancé, MD Burgio, K Peoc'h… - European Journal of …, 2020 - journals.lww.com
Objectives We have confirmed the diagnostic value of protein induced by vitamin K absence
or antagonist-II (PIVKA-II) in a French cohort of patients with hepatocellular carcinoma
(HCC). Herein, we aim to study the biological response under treatment and the prognostic
value of PIVKA-II serum level in patients treated for HCC. Methods Patients with primary
HCC developed chronic liver disease with serum PIVKA-II, and alpha-fetoprotein (AFP)
levels available at baseline and after first HCC treatment [within 3 months (M1–M3) and/or …
以上显示的是最相近的搜索结果。 查看全部搜索结果